Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice Obesity pharmacotherapy: current perspectives and future directions Obesity drugs in clinical development Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors Eligibility & terms of sale This material is sold to qualified laboratory and research buyers for lawful research use only
Metabolic Pharmaceuticals, a subsidiary of Calzada Ltd., had no choice but to terminate all further efforts and funding related to AOD-9604: In 2007, the company that owns Metabolic Pharmaceuticals, Calzada, reported to their shareholders that AOD-9604 showed no promise, and was being abandoned as a weight loss drug
Reader Success Stories "This article helped me immensely
Confirming Your Deficiency With Accurate Testing Before you even think about where to buy B12 shots, theres a crucial first step you simply cant skip: getting tested to prove you have a deficiency
Here's what our happy clients say: "I've struggled with low energy for years,
Injections are all we do